SCHEMBL8799646

SCHEMBL8799646

CCOC(=O)C(CCC(N)C(=O)OC(C)(C)C)(Oc1cccnc1)C(=O)OCC

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CCNC P24863 1/20 0.36
CDK8 P49336 1/20 0.36
GRM2 Q14416 2/20 0.36
LTA4H P09960 1/20 0.36
KMT2A Q03164 1/20 0.35
CNR1 P21554 1/20 0.35
CHRNB2 P17787 3/20 0.34
CHRNA4 P43681 3/20 0.34
TSHR P16473 2/20 0.34
ABCB11 O95342 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
HTR2A P28223 1/20 0.34
PMP22 Q01453 1/20 0.34
PPARA Q07869 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8799924 0.87 CYP1A2 (0.40) MAPK1LTA4HKMT2ACNR1TSHR
SCHEMBL8798762 0.84 LTA4H (0.41) MAPK1SMN1; SMN2GRM2LTA4HKMT2A
SCHEMBL8798260 0.83 LTA4H (0.38) MAPK1SMN1; SMN2LTA4HKMT2ACYP3A4
SCHEMBL8799637 0.78 CYP3A4 (0.49) MAPK1SMN1; SMN2KMT2ACYP3A4
SCHEMBL8798842 0.78 DPP4 (0.40) MAPK1SMN1; SMN2GRM2LTA4HKMT2A
SCHEMBL8799769 0.77 LTA4H (0.41) MAPK1LTA4HKMT2ATSHRABCB11
SCHEMBL8799648 0.76 MAPK1 (0.36) MAPK1SMN1; SMN2CCNCCDK8GRM2
SCHEMBL8800040 0.75 LTA4H (0.42) MAPK1SMN1; SMN2LTA4HKMT2ATSHR
SCHEMBL8633545 0.75 SLC7A5 (0.43) SMN1; SMN2LTA4HKMT2ATSHRCYP1A2
SCHEMBL1969926 0.74 PPARA (0.56) MAPK1SMN1; SMN2CCNCCDK8GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0792878-A2 Geminal carboxylic acids and esters thereof, pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism Dompé S.P.A. (IT) 1997-09-03 EP disclosed